Women’s cancers in China: a spatio-temporal epidemiology analysis

Abstract

Background Women's cancers, represented by breast and gynecologic cancers, are emerging as a significant threat to women's health, while previous studies paid little attention to the spatial distribution of women's cancers. This study aims to conduct a spatio-temporal epidemiology analysis on breast, cervical and ovarian cancers in China, thus visualizing and comparing their epidemiologic trends and spatio-temporal changing patterns. Methods Data on the incidence and mortality of women’s cancers between January 2010 and December 2015 were obtained from the National Cancer Registry Annual Report. Linear tests and bar charts were used to visualize and compare the epidemiologic trends. Two complementary spatial statistics (Moran’s I statistics and Kulldorff’s space–time scan statistics) were adopted to identify the spatial–temporal clusters. Results The results showed that the incidence and mortality of breast cancer displayed slow upward trends, while that of cervical cancer increase dramatically, and the mortality of ovarian cancer also showed a fast increasing trend. Significant differences were detected in incidence and mortality of breast, cervical and ovarian cancer across east, central and west China. The average incidence of breast cancer displayed a high-high cluster feature in part of north and east China, and the opposite traits occurred in southwest China. In the meantime, the average incidence and mortality of cervical cancer in central China revealed a high-high cluster feature, and that of ovarian cancer in northern China displayed a high-high cluster feature. Besides, the anomalous clusters were also detected based on the space–time scan statistics. Conclusion Regional differences were detected in the distribution of women’s cancers in China. An effective response requires a package of coordinated actions that vary across localities regarding the spatio-temporal epidemics and local conditions.

Epidemiologia da mortalidade por câncer de mama no Brasil entre os anos de 2009 e 2019 e a influência de aspectos socioeconômicos e demográficos

“…Em outros países, como na China, tem se reforçado os impactos da queda na taxa de fertilidade e do aumento do peso corporal na elevação da incidência local de câncer de mama, fato que representa sinal de alerta até mesmo para a população brasileira, que apresenta tendências semelhantes. Ademais, outro relevante fator de risco é o próprio sexo feminino, devido à alta quantidade de glândulas mamárias e maior produção de hormônios sexuais, como estrogênio, que incita a proliferação celular e inibe a apoptose mamária (Instituto Nacional de Câncer, 2019a; He et al, 2021).…”

Area-Level Determinants in Colorectal Cancer Spatial Clustering Studies: A Systematic Review

“…Spatial cluster analysis plays an important role in quantifying geographic variation patterns [ 26 , 42 , 50 ]. It is commonly used in disease surveillance, spatial epidemiology, population genetics, landscape ecology, and many other fields, but the underlying principles are the same [ 51 , 52 ].…”

“…However, the term has been vaguely used to refer to a population-based cancer epidemiology due to the complex interaction between multiple factors believed to contribute to such event. Cancer cluster identification is heavily dependent on the accuracy of methodological design used to estimate the local relative risk as compared to the control [ 26 , 27 ]. Besides, spatial analysis of CRC incidence may provide a new knowledge on the relationships between external risk factors and people lifestyle with CRC burden across communities.…”

HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells

“…Ovarian cancers are a group of heterogenous malignancies and are one of the deadliest gynecological cancers with five-year survival close to or less than 50% ( Torre et al, 2018 ). In Chinese population, mortality due to ovarian cancer is rapidly increasing ( He et al, 2021 ). The heterogenous nature of ovarian cancer calls for novel studies to fully understand the disease etiology and identify novel targets of therapy.…”